Skip to content

13F-HR filed by New Leaf Venture Partners, L.L.C.

New Leaf Venture Partners, L.L.C. filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-13, with 10 holding rows worth $97,295,291.

Accession
0000950123-24-011274
Filed
2024-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2024

A holdings report, 10 entries on the cover page, a total value of $97,295,291 stated on the cover page (in dollars after the unit check, H1), rows summing to $97,295,292 with VALUE read as dollars as filed, 13F file number 028-16681. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
EDGEWISE THERAPEUTICS INC28036F105COM1,553,661$41,467,212dollars as filed
ARVINAS INC04335A105COM1,434,721$35,337,178dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock141,000$7,205,100dollars as filed
RALLYBIO CORP75120L100COM3,301,603$3,862,876dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM150,706$2,783,540dollars as filed
COGENT BIOSCIENCES INC19240Q201COM250,765$2,708,262dollars as filed
PASSAGE BIO INC702712100COM2,497,922$1,748,545dollars as filed
ALECTOR INC014442107COMMON STOCK339,569$1,582,392dollars as filed
ITERUM THERAPEUTICS PLCG6333L200COM345,020$376,072dollars as filed
X4 Pharmaceuticals, Inc.98420X103COM335,000$224,115dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-24-011274this filing2024-11-13acceptance time not in the bulk data set